title: Medical treatment for primary sclerosing cholangitis: risk versus benefit.
authors.affiliation: Division of Gastroenterology and Hepatology Mayo Clinic and Foundation Rochester, MN, USA.
authors.forename: P
authors.initials: P
authors.lastname: Angulo
authors.forename: K D
authors.initials: KD
authors.lastname: Lindor
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects; D015209:Cholangitis, Sclerosing / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D014580:Ursodeoxycholic Acid; D011239:Prednisolone; D001379:Azathioprine